BioCryst Pharmaceuticals, Inc. R&D Expenses

R&D Expenses of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including R&D Expenses growth rates and interactive chart. Research and development (R&D) expenses are associated with the research and development of a company's goods or services. A company generally incurs R&D expenses in the process of finding and creating new products or services. It is an operating expense and can be deducted from a company's income taxes.

Highlights and Quick Summary

  • R&D Expenses for the quarter ending September 30, 2022 was $52.7 Million (a -14.92% decrease compared to previous quarter)
  • Year-over-year quarterly R&D Expenses decreased by -16.98%
  • Annual R&D Expenses for 2021 was $209 Million (a 69.81% increase from previous year)
  • Annual R&D Expenses for 2020 was $123 Million (a 14.85% increase from previous year)
  • Annual R&D Expenses for 2019 was $107 Million (a 26.13% increase from previous year)
  • Twelve month R&D Expenses ending September 30, 2022 was $244 Million (a 1.15% increase compared to previous quarter)
  • Twelve month trailing R&D Expenses increased by 16.67% year-over-year
Trailing R&D Expenses for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$244 Million $241 Million $232 Million $209 Million
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical R&D Expenses of BioCryst Pharmaceuticals, Inc.

Most recent R&D Expensesof BCRX including historical data for past 10 years.

Interactive Chart of R&D Expenses of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. R&D Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $52.74 $61.99 $65.36 –
2021 $63.53 $49.97 $52.87 $42.44 $208.81
2020 $35.35 $30.25 $27.5 $29.87 $122.96
2019 $26.77 $25.12 $27.68 $27.49 $107.07
2018 $23.43 $22.01 $21.01 $18.44 $84.89
2017 $16.92 $17.51 $15.76 $16.77 $66.96
2016 $12.16 $14.11 $14.17 $20.58 $61.01
2015 $19.05 $20.07 $16.52 $17.12 $72.76
2014 $18.51 $13.04 $11.07 $9.18 $51.8
2013 $15.47 $7.74 $11.53 $7.22 $41.94
2012 $8.79 $12.07 $12.78 $15.53 $49.16

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com